Tag Archives: Alzheimer’s

Finding that statins could slow dementia stimulates further research

Blood fat-lowering statins could slow the progression of Alzheimer’s disease, at least for some patients. This is the result of a new study led by Karolinska Institutet published in Alzheimer Research and Therapy. But the researchers are cautious in their interpretations and see the results as a first step in a research journey that may eventually provide the answer.

Photo by MART PRODUCTION on Pexels.com

A new study shows that people with Alzheimer’s dementia deteriorated more slowly in their cognitive functions if they were also treated with a lipid-lowering statin, compared to those who were not treated. However, the study is an observational study where the researchers have compared data on the patients from a registry and therefore cannot answer whether there really is a causal relationship. Thus, the researchers are cautious in their interpretations.

2 Comments

Filed under Uncategorized

Study reveals broader impact of Alzheimer’s on brain function

Scientists at The University of Texas at Dallas Center for Vital Longevity (CVL) have published new evidence that shows changes in brain network patterns that occur in early-stage Alzheimer’s disease differ from those associated with normal aging.

Alzheimer’s disease and aging are associated with distinct patterns of brain network disruption. Alzheimer’s (left) exerts widespread impacts on brain connectivity, disrupting both higher order cognitive networks and sensory and motor networks. In contrast, healthy aging (right) is limited to disruption of cognitive networks and spares sensory and motor networks.

The findings, published Nov. 15 in The Journal of Neuroscience, also show that the impact of Alzheimer’s on brain function is broader than previously believed. In addition to detecting characteristic changes in the brain circuits supporting memory and attention as expected, the researchers found distinct changes in circuits involved in sensory and motor processing.

Leave a comment

Filed under Uncategorized

High metabolism is an early sign of Alzheimer’s disease

An early phase in the process of developing Alzheimer’s disease is a metabolic increase in a part of the brain called the hippocampus, report researchers from Karolinska Institutet in a study published in Molecular Psychiatry. The discovery opens up for new potential methods of early intervention. 

Photo by Tima Miroshnichenko on Pexels.com

Alzheimer’s disease is the most common form of dementia and strikes about 20,000 people in Sweden every year. Researchers now show that a metabolic increase in the mitochondria, the cellular power plants, is an early indicator of the disease.

Leave a comment

Filed under Uncategorized

Mount Sinai researchers first to develop age prediction model on human brain tissue using artificial intelligence

Bottom Line:The aging brain undergoes structural and cellular changes that can impact function and increase susceptibility to neuro-degenerative disorders like Alzheimer’s disease. Age acceleration—or the differences between biological and chronological age—in the brain can reveal insights about mechanisms and normal functions of one of the body’s most important organs. It can also explain age-related changes and functional decline, as well as identify early changes related to diseases, indicating the onset of a brain disorder.

Mount Sinai researchers say they have, for the first time ever, used AI to develop an algorithm they term “HistoAge” which predicts age at death based on the cellular composition of human brain tissue specimens with an average accuracy of within 5.45 years. This powerful tool can also identify neuroanatomical regions vulnerable to age-related changes, an indicator of potential cognitive diseases.

How: The researchers examined a collection of almost 700 digitized images of slides with human hippocampal sections from aged brain donors to develop the histological brain age estimation algorithm. The hippocampus is known to be involved in both brain aging and age-dependent neurodegenerative diseases, and thus is an ideal region for this analysis. The team then trained a machine learning model to estimate a person’s age at death based solely on the digitized section, a task that is impossible for a human observer to perform with any degree of accuracy. They used the difference between the model-predicted age and actual age to derive the amount of age acceleration in the brain.

Results: When compared with current measures of age acceleration (e.g., DNA methylation), they found that HistoAge-based age acceleration had stronger associations with cognitive impairment, cerebrovascular disease, and the levels of Alzheimer’s-type abnormal degenerative protein aggregation. The study found that the HistoAge model is a reliable, independent metric for determining brain age and understanding factors that drive neurodegeneration over time.

Why the Research Is Interesting:The researchers said the HistoAge model, and other subsequent similar algorithms, represent an entirely new paradigm for assessing aging and neurodegeneration in human samples and can easily be deployed at scale in clinical and translational research laboratories. Further, this approach provides more rigorous, unbiased and robust metrics of cellular changes underlying degenerative diseases. The team will next build a multicenter collaboration to develop a large AI-ready dataset that will be used to develop even more powerful AI models that have the potential to transform and enhance our understanding of brain diseases.

Said Mount Sinai’s Dr. Crary of the research:
“AI’s disruptive influence on brain research is a paradigm shift propelling us towards the next generation of cures. The HistoAge model will enable us to uncover crucial causal aspects of debilitating brain diseases such as Alzheimer’s disease.”

Said Mount Sinai’s Dr. Farrell of the research:
Using the latest computational approaches, like AI, on human tissue samples from Mount Sinai’s vast and diverse collections is a shift in the way we assess human diseases. Our novel HistoAge model is just one example of the way AI is paving the way for further discovery about the mechanisms of aging and neurodegeneration. Clinical scientists are increasingly using AI in research and diagnostic settings. It’s a tool that is revolutionizing medicine and we are excited to be leaders in this space, optimizing machine learning—not to replace our Health System’s commitment to compassionate care, but to improve diagnosis and treatment for all patients.

Said Mount Sinai’s Dr. Marx of the research:
This model opens the floodgates for a slew of fascinating and essential analyses that bring us closer to finally understanding the aging brain and age-related brain diseases such as Alzheimer’s. This is the first time we have been able to put a number to how much aging there is in the brain in pathology. With this approach, we can discover genes that protect against brain aging or genes that make aging worse in the brain, as well as discover the environmental risk factors that make individuals’ brains age faster.

Leave a comment

Filed under Uncategorized

Exercise-induced hormone irisin may reduce Alzheimer’s disease plaque in the brain

Researchers who previously developed the first 3D human cell culture models of Alzheimer’s disease (AD) that displays two major hallmarks of the condition—the generation of amyloid beta deposits followed by tau tangles—have now used their model to investigate whether the exercise-induced muscle hormone irisin affects amyloid beta pathology.

Photo by cottonbro studio on Pexels.com

As reported in the journal Neuron, the Massachusetts General Hospital (MGH)–led team has uncovered promising results suggesting that irisin-based therapies might help combat AD.

Physical exercise has been shown to reduce amyloid beta deposits in various mouse models of AD, but the mechanisms involved have remained a mystery.

Leave a comment

Filed under Uncategorized

New blood test gives very high accuracy to screen for Alzheimer’s disease

In recent years, a lot of effort has been put on developing biomarkers in blood that could potentially help to identify Alzheimer’s disease (AD). Tau protein, in particular its phosphorylated variant (p-tau) – and one of the main proteins involved in AD pathology – has been the focus of extensive research and developments the last years.

Photo by MART PRODUCTION on Pexels.com

The new blood-based p-tau biomarkers, especially a variant called p-tau217, have shown great promise as clinically useful tools to screen patients with memory problems or other early cognitive symptoms suggestive of early Alzheimer’s disease.

However, even if promising, a concern has been that classifying early patients into either having “AD or not AD” will still result in a rather high percentage of false positives (individuals with a positive test result who do not have AD) and false negatives (individuals with a negative test result who prove to have AD based on other examinations such as amyloid PET scans).

Leave a comment

Filed under Uncategorized

Genetic variants cut Alzheimer’s disease risk – UCL

While there is no known ‘silver bullet’ for Alzheimer’s disease it appears that there may be some ‘luck of the draw’ genetic variants that help.

A DNA study of over 10,000 people by University College of London (UCL) scientists has identified a class of gene variants that appear to protect against Alzheimer’s disease.

The findings, published in Annals of Human Genetics, suggest these naturally occurring gene variants reduce the functioning of proteins called tyrosine phosphatases, which are known to impair the activity of a cell signalling pathway known as PI3K/Akt/GSK-3β. This pathway is important for cell survival.

dnastructure.jpg

The research builds on previous studies in mice and rats, which suggested inhibiting the function of these proteins might be protective against Alzheimer’s disease, but this is the first time such an effect has been demonstrated in people.

Researchers believe the PI3K/Akt/GSK-3β signalling pathway could be a key target for therapeutic drugs and the findings also strengthen evidence that other genes could be linked to either elevated or reduced risk of Alzheimer’s disease.

“These results are quite encouraging. It looks as though when naturally-occurring genetic variants reduce the activity of tyrosine phosphatases then this makes Alzheimer’s disease less likely to develop, suggesting that drugs which have the same effect might also be protective,” said the study’s lead author, Professor David Curtis (UCL Genetics Institute).

Continue reading

Leave a comment

Filed under Alzheimer's, Alzheimer's disease, dementia, DNA, genetics

New blood test for Alzheimer’s – Study

There is possible good news is the study of Alzheimer’s disease. Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.

MIT-Mood-Disoders

Currently, a major support in the diagnostics of Alzheimer’s disease is the identification of abnormal accumulation of the substance beta-amyloid, which can be detected either in a spinal fluid sample or through brain imaging using a PET scanner. Continue reading

Leave a comment

Filed under aging brain, Alzheimer's, Alzheimer's disease, blood test, brain, brain function

How exercise may protect against Alzheimer’s – Study

As a senior citizen whose family has Alzheimer’s and dementia on both sides I am keenly interested in anything on the subject. Herewith a study published in Nature Medicine.

Athletes know a vigorous workout can release a flood of endorphins: “feel-good” hormones that boost mood. Now there’s evidence that exercise produces another hormone that may improve memory and protect against Alzheimer’s disease, according to a study co-led by Ottavio Arancio, MD, PhD, a researcher at Columbia University’s Vagelos College of Physicians and Surgeons and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain.

neuroimaging-social-exclusion-radicalization-neuroscineews

Physical activity is known to improve memory, and studies suggest it may also reduce the risk of Alzheimer’s disease. But researchers don’t understand why. Continue reading

5 Comments

Filed under aging, Alzheimer's disease, Alzheimer's risk, dementia, Exercise, exercise and brain health, exercise benefits, successful aging

Alzheimer’s Disease Redefined

Researchers have published a new study framework that defines Alzheimer’s disease by brain changes, not symptoms.

“NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease” was published in the April 2018 issue of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. First author Clifford R. Jack, Jr., M.D., of Mayo Clinic Rochester, MN and colleagues propose shifting the definition of Alzheimer’s disease in living people – for use in research – from the current one, based on cognitive changes and behavioral symptoms with biomarker confirmation, to a strictly biological construct. This represents a major evolution in how we think about Alzheimer’s.

alzheimers-redefined-neurosciencenews-public.jpg

In 2011, the Alzheimer’s Association (AA) and the National Institute on Aging (NIA) at the U.S. National Institutes of Health convened experts to update the diagnostic guidelines for Alzheimer’s disease. NeuroscienceNews.com image is in the public domain.

Understanding and effectively treating Alzheimer’s disease and other dementias may be the most difficult challenge for the medical/scientific community this century. The field has experienced monumental challenges developing new and effective drug therapies, not the least of which was the discovery that – until recently – clinical trials were conducted where up to 30% of participants did not have the Alzheimer’s disease-related brain change targeted by the experimental drug. Continue reading

Leave a comment

Filed under aging brain, Alzheimer's, Alzheimer's disease, brain, brain damage, brain function, brain health, dementia

Massaging Brain Cells to Fight Alzheimer’s

I have written repeatedly about physical exercise benefiting the brain. It seems that now a new study has found a way to actually stimulate the brain cells which may benefit individuals suffering from Alzheimer’s Disease.

Some researchers at Montana State University have a light touch when it comes to unraveling the mysteries of the brain and exploring new ways to treat diseases like Alzheimer’s.

8a247afb6a437b3f2aca2337f66d88a9

A team led by Anja Kunze, assistant professor in the Department of Electrical and Computer Engineering, uses tiny magnets to stretch small branches of individual brain cells in her lab.

“It’s a very gentle force,” Kunze said. “It would be like getting a massage.” Continue reading

2 Comments

Filed under Alzheimer's, Alzheimer's disease, dementia, Exercise, exercise and brain health, exercise benefits

Can you get Alzheimer’s when you are young?

I used to attend regularly a program at Northwestern Memorial Hospital called ‘Healthy Transions.’ It was for folks over 55 years old and dealt with the situations they would encounter as they aged. The most popular talks by far were the ones on MCI – mild cognitive impairment, and Alzheimer’s Disease. It’s not surprising that as we age we get serious concerns about our brains functioning fully.

8a247afb6a437b3f2aca2337f66d88a9.gif

Here is what Sharecare had to say on the subject: We rightly associate Alzheimer’s disease with an older population. Most people who develop this progressive brain disorder are age 65 and older. Currently some 5.5 million Americans—two-thirds of them women—live with the disease. But hidden within that estimate, a smaller number—approximately 200,000 adults—develop the condition under the age of 65. When this happens, it’s called younger-onset, or early-onset Alzheimer’s. “Alzheimer’s is just one type of dementia, and given the frequency of early-onset it’s somewhat uncommon,” says H. Rai Kakkar, MD, a neurologist at Presbyterian/St. Luke’s Medical Centerin Denver, Colorado.

How is early-onset different?
Early-onset Alzheimer’s disease (EOAD) is the same as Alzheimer’s disease in terms of progressive deterioration of cognitive function, but there are differences in causes. Some cases are the result of familial Alzheimer’s disease (FAD), caused by an inherited change in one of several specific genes. Continue reading

3 Comments

Filed under Alzheimer's, Alzheimer's disease, Alzheimer's risk, cognitive decline, dementia

November is Alzheimer’s Awareness Month

Regular readers know that I and my family have had several members suffer from Alzheimer’s and dementia. As this is Alzheimer’s Awareness Month I thought I would round up some of my Alzheimer’s posts and list their links for you. But, before you start on them, I need to direct you to my Page – Important facts about your brain (and exercise benefits.)

 

c80992a1012118373be3f673cecdf16bf4f6c32b_original

These are in reverse chronological order:

Memory loss reversed in early Alzheimer’s – Study

Cholesterol levels linked to Alzheimer’s – MNT

Some possibly good news on Alzheimer’s Disease- TED talk

Blocking a key enzyme may reverse Alzheimer’s memory loss – MIT Study

What about Alzheimer’s in the family? – Harvard

Extra virgin olive oil may prevent Alzheimer’s Disease

Weight and Alzheimer’s risk – Tufts

Can gut bacteria affect Alzheimer’s?

Can exercise help people at risk for Alzheimer’s?

Get the jump on Alzheimer’s and dementia – Rush

Can Ayurveda help with Alzheimer’s and dementia?

How to reduce your chances of Alzheimer’s – Harvard

Does forgetting things mean I am coming down with Alzheimer’s?

Those are all from 2017 except the final one which was last year. Feel free to search the blog for more in you want to read further on the subject.

Tony

 

Leave a comment

Filed under Alzheimer's, Alzheimer's disease, Alzheimer's risk, dementia

Some possibly good news on Alzheimer’s Disease – TED talk

Regular readers know that I have lost three family members to Alzheimer’s Disease and/or dementia. So, anything having to do with those afflictions I find relevant.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community.

Brain scientist Owen Carmichael is preparing for his Alzheimer’s diagnosis. And for his children’s Alzheimer’s diagnosis. And he’s asking an important question: Can we use basic health tools to train our brain to resist the effects of the disease?

DR. OWEN CARMICHAEL has a Ph.D. in robotics and a passion for brain science. Owen is an associate professor and the Director of Biomedical Imaging at the Pennington Biomedical Research Center. He uses technology not only to better understand how the wiring of your brain affects your ability to think, but also how your actions and your environment can affect the wiring of the brain. In other words: are we able to set ourselves up to be mentally healthy throughout our lives, or are we destined for our brains to turn our lives one way or another? Owen has been studying these questions for years.

Tony

Leave a comment

Filed under aging, aging brain, Alzheimer's, Alzheimer's disease, Alzheimer's risk, dementia, successful aging

To what extent is dementia preventable?

Regular readers know that my family has a history of Alzheimer’s Disease and/or dementia. This is true on both my mother’s and father’s side. So, at 77, I am totally focused on anything that relates to these mental conditions. The following is from the Keck School of Medicine at USC by Erica Rheinschild.

Experts say that one-third of the world’s dementia cases could be prevented by managing lifestyle factors such as hearing loss, hypertension and depression.

 

17-07-2046-Dementia-IG_Final_2-768x576.jpg

This remarkable fact was part of a report by the first Lancet Commission on Dementia Prevention and Care that was presented at the Alzheimer’s Association International Conference (AAIC) 2017 and published in The Lancet. The report also highlighted the beneficial effects of nonpharmacologic interventions such as social contact and exercise for people with dementia. Continue reading

Leave a comment

Filed under aging, aging brain, Alzheimer's, Alzheimer's disease, Alzheimer's risk, cardio exercise, dementia, Exercise, exercise benefits, successful aging

Could changes in thinking skills be reversible dementia? – Harvard

Regular readers know that I have had a number of Alzheimer’s and dementia occurrences in my immediate family. So, I am especially sensitive to anything related to dementia. The following is from Heidi Godman, Executive Editor, Harvard Health Letter.

We use the term “dementia” to describe a number of conditions that cause permanent thinking skills changes, such as memory loss and confusion. The most common kind of dementia is Alzheimer’s disease, which is characterized by clumping proteins that get tangled in and around brain cells, eventually causing them to die. The second most common type of dementia is vascular dementia, caused by decreased blood flow to the brain from atherosclerosis—the accumulation of fatty deposits on artery walls.

c80992a1012118373be3f673cecdf16bf4f6c32b_original

Once dementia strikes, the damage is permanent, and we don’t have many treatment options. So, before a diagnosis is made, it’s crucial to rule out whether the causes for dementia are actually reversible conditions. Continue reading

3 Comments

Filed under aging brain, Alzheimer's, Alzheimer's disease, Alzheimer's risk, brain, brain function, brain health, dementia